LANCIOTTI, MICHELE
 Distribuzione geografica
Continente #
EU - Europa 15.706
NA - Nord America 4.806
AS - Asia 1.758
SA - Sud America 230
Continente sconosciuto - Info sul continente non disponibili 159
AF - Africa 66
OC - Oceania 27
Totale 22.752
Nazione #
IT - Italia 8.468
PL - Polonia 4.999
US - Stati Uniti d'America 4.726
RU - Federazione Russa 853
SG - Singapore 461
CN - Cina 353
HK - Hong Kong 238
NL - Olanda 233
FR - Francia 221
VN - Vietnam 211
IE - Irlanda 207
SE - Svezia 204
BR - Brasile 177
KR - Corea 114
CH - Svizzera 111
DE - Germania 90
FI - Finlandia 89
GB - Regno Unito 74
IN - India 62
UA - Ucraina 58
CA - Canada 52
JP - Giappone 52
ID - Indonesia 49
BD - Bangladesh 44
TR - Turchia 39
ES - Italia 27
JO - Giordania 27
AU - Australia 26
TH - Thailandia 19
BE - Belgio 18
AR - Argentina 16
CI - Costa d'Avorio 15
NP - Nepal 15
MX - Messico 13
PK - Pakistan 11
RO - Romania 11
IQ - Iraq 10
MY - Malesia 10
TN - Tunisia 10
CL - Cile 9
EC - Ecuador 9
NG - Nigeria 9
IR - Iran 8
MA - Marocco 8
ZA - Sudafrica 8
PE - Perù 7
AT - Austria 5
DK - Danimarca 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
EG - Egitto 4
GR - Grecia 4
HR - Croazia 4
IL - Israele 4
KE - Kenya 4
PH - Filippine 4
AM - Armenia 3
AZ - Azerbaigian 3
BG - Bulgaria 3
CO - Colombia 3
ET - Etiopia 3
HN - Honduras 3
NO - Norvegia 3
PY - Paraguay 3
SV - El Salvador 3
VE - Venezuela 3
BO - Bolivia 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DM - Dominica 2
EE - Estonia 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
SM - San Marino 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BW - Botswana 1
CG - Congo 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GI - Gibilterra 1
KH - Cambogia 1
LB - Libano 1
LT - Lituania 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
Totale 22.589
Città #
Warsaw 4.985
Santa Clara 720
Milan 643
Rome 585
Ashburn 445
Fairfield 347
Singapore 321
Florence 259
San Jose 219
Dublin 205
Hong Kong 191
Chandler 185
Naples 181
Turin 166
Woodbridge 162
Houston 145
Bologna 139
Council Bluffs 133
Seattle 132
Cambridge 129
Wilmington 125
Beijing 117
Seoul 113
Bari 82
Torino 82
Catania 76
Bern 73
Dong Ket 70
Princeton 67
Los Angeles 66
Dallas 64
Ann Arbor 62
Buffalo 60
The Dalles 57
Palermo 56
Tokyo 52
Genoa 51
Boardman 48
Lauterbourg 47
Altamura 43
Ho Chi Minh City 42
Parma 41
Jakarta 40
Lawrence 38
New York 38
Padova 38
Boston 36
Modena 36
Mumbai 36
Medford 34
Pisa 34
Hanoi 31
Helsinki 31
Trieste 31
Bergamo 30
Brescia 30
Verona 29
Moscow 28
Napoli 28
Venice 27
Phoenix 26
Livorno 24
Melbourne 23
Treviso 23
Hefei 22
Pescara 22
Reggio Emilia 22
Izmir 21
Perugia 21
Toronto 21
Vicenza 21
Cagliari 20
Novara 19
Monza 18
Prato 18
Redwood City 18
Clifton 17
Cosenza 17
Falls Church 17
Jacksonville 17
San Diego 17
Dearborn 16
Frankfurt am Main 16
Imola 16
Salerno 16
Abidjan 15
Caserta 15
Orem 15
Springfield 15
Taranto 15
Genova 14
Paris 14
Shanghai 14
Trento 14
Asti 13
Bangkok 13
Lucca 13
Messina 13
Ravenna 13
Rimini 13
Totale 13.078
Nome #
IL COINVOLGIMENTO NEOPLASTICO DELL' APICE PROSTATICO È UN FATTORE PROGNOSTICO INDIPENDENTE DI PROGRESSIONE DI MALATTIA DOPO PROSTATECTOMIA RADICALE 3.644
IL POSIZIONAMENTO DELLO STENT URETERALE NELLA PIELOPLASTICA LAPAROSCOPICA:TECNICA ANTEROGRADA VS RETROGRADA 2.111
CONFRONTO TRA PROSTATECTOMIA RADICALE NERVE-SPARING BILATERALE EFFETTUATA CON TECNICA ROBOTICA ANTEROGRADA ED OPEN ANTEROGRADA: RISULTATI DI UN SINGOLO CENTRO AD ALTO VOLUME CHIRURGICO 1.189
RISULTATI FUNZIONALI DELLA PROSTATECTOMIA RADICALE ANTEROGRADA PER IL TRATTAMENTO DEL TUMORE PROSTATICO CLINICAMENTE LOCALIZZATO. 1.155
PROSTATECTOMIA RADICALE A CIELO APERTO ANTEROGRADA VS. RETROGRADA PER ETP PROSTATA IN CASI AD ALTO RISCHIO: ANALISI DEI MARGINI CHIRURGICI IN SETTECENTO PAZIENTI TRATTATI IN CENTRI DI RIFERIMENTO TERZIARI 1.005
RUOLO DELL’INTERAZIONE TRA FIBROBLASTI STROMALI E CELLULE DI CARCINOMA PROSTATICO NELL’ACQUISIZIONE DI UN FENOTIPO METASTATICO. 836
IL VALORE PROGNOSTICO DELLA CROMOGRANINA A (CGA) PREOPERATORIA NEL CARCINOMA PROSTATICO CLINICAMENTE LOCALIZZATO TRATTATO CON PROSTATECTOMIA RADICALE 788
Pieloplastica laparoscopica transperitoneale sec. anderson-hynes: note di tecnica e risultati d120 casi consecutivi 482
CARATTERISTICHE ANATOMO PATOLOGICHE E IMPATTO PROGNOSTICO DELL'INVASIONE DELLA CAPSULA PERITUMORALE IN PAZIENTI CON RCC A CELLULE CHIARE TRATTATI MEDIANTE CHIRURGIA CONSERVATIVA 401
TRATTAMENTO VIDEOLAPAROSCOPICO DI ENDOMETRIOSI VESCICALE TRIGONALE CON COINVOLGIMENTO AB ESTRINSECO DELL’URETERE PELVICO : PRESENTAZIONE DI UN CASO CLINICO 379
Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative 377
Management of sexual dysfunction due to central nervous system disorders: A systematic review 374
Zoledronic acid impairs stromal reactivity by inhibiting M2-macrophages polarization and prostate cancer-associated fibroblasts. 369
Clinical and pathological outcome after radical and nerve sparing anterograde prostatectomy for bioptic Gleason score ≥ 7 and PSA ≥ 10 ng/ml 363
CURRENT STRATEGIES FOR DIAGNOSIS AND TREATMENT OF BENIGN TUMORS OF SEMINAL VESICLES: A SYSTEMATIC REVIEW OF THE LITERATURE 347
ENUCLEAZIONE TUMORALE VERSUS NEFRECTOMIA RADICALE NELTRATTAMENTO DEL CARCINOMA RENALE INTRACAPSULARE DI DIAMETRO<7 CM 341
HIYSTOPATHOLOGICAL ANALYSIS OF PERITUMORALPSEUDOCAPSULE AND SURGICAL MARGINS STATUS IN RCCAFTER TUMOR ENUCLEATION: PROSPECTIVE SINGLE CENTERSTUDY 337
ANALYSIS OF THE CLINICAL PARAMETERS COMMONLY USED TO CHOOSE NERVE-SPARING PROSTATECTOMY FOR PATIENTS WITH POSITIVE BIOPSY AT THE TRANSITION ZONE ALONE 324
SIMPLE ENUCLEATION VERSUS RADICAL NEPHRECTOMY IN THE TREATMENT OF pT1a AND pT1b RENAL CELL CARCINOMA 322
RUOLO DEI FATTORI DI RISCHIO METABOLICI NEL RECUPERO FUNZIONALE DOPO PROSTATECTOMIA RADICALE ROBOTICA: DATI PRELIMINARI DI UN SINGOLO CENTRO 314
Quality of life in women undergoing urinary diversion for bladder cancer: results of a multicenter study among long-term disease-free survivors. 311
The role of M1 and M2 macrophages in prostate cancer in relation to extracapsular tumor extension and biochemical recurrence after radical prostatectomy 311
Simple enucleation versus radical nephrectomy in the treatment of pt1a and pt1b renal cell carcinoma 309
ROLE OF STROMAL FIBROBLASTS INTERACTION WITH PROSTATIC CANCER CELLS IN ACHIEVEMENT OF METASTATIC PHENOTYPE. 304
CONFRONTO DEI RISULTATI ONCOLOGICI E DELLE COMPLICANZE PERIOPERATORIE TRA PROSTATECTOMIA OPEN E ROBOTICA: MATCHED PAIR ANALYSIS SU MILLE PROCEDURE ANTEROGRADE EFFETTUATE IN UN SINGOLO CENTRO AD ALTO VOLUME. 292
Role of stromal fibroblasts interaction with prostatic cancer cells in achievement of metastatic phenotype. 291
CONTROLLO SUTURELESS DELL’EMOSTASI DURANTE NEFRECTOMIA PARZIALE LAPAROSCOPICA PER IL TRATTAMENTO DELLE PICCOLE MASSE RENALI 288
THE PROGNOSTIC ROLE OF PREOPERATIVE CHROMOGRANIN A IN CLINICALLY LOCALISED PROSTATE CANCER TREATED WITH RADICAL PROSTATECTOMY 279
POSSIBLE BIOMARKERS FOR PROSTATE CANCER: DEVELOPMENT AND VALIDATION OF A FULLY AUTOMATED, RAPID, HIGH THROUGH OUT SPME-FAST GC-MS METHOD USING A NEW IONIC LIQUID COLUMN FOR THE DETERMINATION OF SARCOSINE AND N-ETHYLGLYCINE IN URINE AND URINARY SEDIMENTS 278
Urinary and sexual outcomes in long-term (5+ years) prostate cancer disease free survivors after radical prostatectomy. 273
CARATTERISTICHE ANATOMOPATOLOGICHE E PROGRESSIONE NEOPLASTICA DOPO PROSTATECTOMIA RADICALE ANTEROGRADA NEI PAZIENTI CON PSA PREOPERATORIO A 20 NG/ML 270
URETHRAL PRESERVATION AND ANASTOMOTIC TECHNIQUE DURING OPEN ANTEGRADE RADICAL PROSTATECTOMY: FUNCTIONAL AND ONCOLOGICAL RESULTS 269
RISULTATI E INDICAZIONI ALLA NSS SUTURELESS VIDEO LAPAROSCOPICA PER IL TRATTAMENTO DELLE PICCOLE MASSE RENALI 264
The impact of prior TURP on radical prostatectomy surgical margins: A multicenter analysis and members of the mirror study, LUNA foundation 263
Proximal hypospadias repair with bladder mucosal graft: Our 10 years experience 259
PATHOLOGICAL OUTCOMES IN PATIENTS CANDIDABLE FOR ACTIVE SURVEILLANCE TREATED WITH RADICAL PROSTATECTOMY. ARE THEY REALLY LOW RISK PATIENTS? 255
MONOLATERAL NERVE-SPARING PROSTATECTOMY: REVIEW OF INDICATIONS, FUNCTIONAL AND ONCOLOGIC OUTCOME 248
A comparison of different oral therapies versus no treatment for erectile dysfunction in 196 radical nerve-sparing radical prostatectomy patients 223
External validation of the updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection. 205
Fully automated solid-phase microextraction-fast gas chromatography-mass spectrometry method using a new ionic liquid column for high-throughput analysis of sarcosine and N-ethylglycine in human urine and urinary sediments. 201
ANALYSIS OF THE CLINICAL PARAMETERS COMMONLY USED TO CHOOSE FOR A NERVE-SPARING PROSTATECTOMY IN PATIENTS WITH POSITIVE BIOPSY AT THE TRANSITION ZONE ALONE 184
null 179
RECIPROCAL METABOLIC REPROGRAMMING THROUGH LACTATE SHUTTLE COORDINATELY INFLUENCES TUMOR-STROMA INTERPLAY. 166
Current indications and results of orthotopic ileal neobladder for bladder cancer 166
Serenoa repens + selenium + lycopene vs tadalafil 5 mg for the treatment of lower urinary tract symptoms secondary to benign prostatic obstruction: a Phase IV, non-inferiority, open-label, clinical study (SPRITE study) 164
Histopathological validation of the Surface-Intermediate-Base (SIB) margin score for standardized reporting of resection techniques during nephron-sparing surgery (NSS) 160
Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma. 157
Prognostic role of histological necrosis for nonmetastatic clear cell renal cell carcinoma: correlation with pathological features and molecular markers. 157
Influence of serum testosterone on urinary continence and sexual activity in patients undergoing radical prostatectomy for clinically localized prostate cancer. 152
Prognostic role of perineural invasion in 239 consecutive patients with pathologically organ-confined prostate cancer. 151
The role of free to total PSA ratio in prediction of extracapsular tumor extension and biochemical recurrence after radical prostatectomy in patients with PSA between 4 and 10 ng/ml. 141
The prognostic role of preoperative chromogranin A expression in prostate cancer after radical prostatectomy. 124
Totale 22.752
Categoria #
all - tutte 39.357
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.357


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022723 0 0 94 64 50 38 42 44 52 59 97 183
2022/20232.195 132 161 119 129 197 244 239 236 248 105 180 205
2023/20241.889 131 103 166 163 97 153 166 196 100 183 204 227
2024/20253.842 240 369 338 516 779 377 183 275 308 145 176 136
2025/20263.424 349 404 204 232 316 203 436 185 259 242 196 398
2026/2027491 170 102 219 0 0 0 0 0 0 0 0 0
Totale 22.752